Lonza | LONN - Cash And Equivalent

Stock Price
481.50
Daily Change
-6.80 -1.39%
Monthly
-10.54%
Yearly
-15.02%
Q1 Forecast
468.93

Lonza reported CHF1.11B in Cash and Equivalent for its fiscal semester ending in December of 2024.





Cash And Equivalent Change Date
Akzo Nobel EUR 1.55B 47M Jun/2025
Alcon AG USD 1.5B 90M Sep/2025
Almirall EUR 337.77M 14.83M Dec/2025
AstraZeneca USD 8.14B 1.08B Sep/2025
BASF EUR 2.67B 811M Dec/2025
Bayer EUR 5.9B 1.34B Sep/2025
Beiersdorf EUR 1.17B 40M Jun/2025
Covestro EUR 604M 115M Sep/2025
Demant DKK 1.33B 188M Dec/2025
Fresenius EUR 1.23B 1.16B Jun/2025
Fresenius Medical Care EUR 1.58B 326.57M Dec/2025
Geberit CHF 403.6M 4.1M Mar/2025
Genmab DKK 1.3B 323M Jun/2025
Givaudan CHF 603M 3M Jun/2024
GlaxoSmithKline GBP 3.3B 303M Sep/2025
GN Store Nord DKK 767M 363M Sep/2025
Hikma Pharmaceutical USD 236M 48M Jun/2025
Johnson Matthey GBP 542M 49M Jun/2024
Merck EUR 2.25B 1.08B Sep/2025
Novartis USD 9.56B 2.9B Sep/2025
Philips EUR 1.91B 90M Sep/2025
Roche Holding CHF 7.55B 579M Jun/2025
Sanofi EUR 7.66B 1.25B Dec/2025
Sika AG CHF 1.87B 1.18B Dec/2022
Solvay EUR 410M 77M Sep/2025
UCB EUR 1.57B 1.14B Dec/2024